Allgens Medical Technology CO., LTD. (688613.SS)
CNY 16.84
(-0.12%)
CNY 16.84
(-0.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 54.23 Million CNY | -43.04% |
| 2022 | 95.21 Million CNY | -21.17% |
| 2021 | 120.78 Million CNY | 35.8% |
| 2020 | 88.94 Million CNY | 31.22% |
| 2019 | 67.78 Million CNY | 105.5% |
| 2018 | 32.98 Million CNY | 40.17% |
| 2017 | 23.53 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 2.28 Million CNY | -67.08% |
| 2024 Q3 | -4.33 Million CNY | -289.75% |
| 2024 Q1 | 6.93 Million CNY | 230.32% |
| 2023 Q4 | 2.1 Million CNY | -88.7% |
| 2023 Q2 | 16.9 Million CNY | -8.7% |
| 2023 Q1 | 18.51 Million CNY | -38.57% |
| 2023 FY | 54.23 Million CNY | -43.04% |
| 2023 Q3 | 18.59 Million CNY | 10.01% |
| 2022 Q1 | 13.14 Million CNY | -63.24% |
| 2022 Q2 | 19.68 Million CNY | 49.69% |
| 2022 FY | 95.21 Million CNY | -21.17% |
| 2022 Q4 | 30.13 Million CNY | -6.54% |
| 2022 Q3 | 32.24 Million CNY | 63.84% |
| 2021 FY | 120.78 Million CNY | 35.8% |
| 2021 Q2 | 29.19 Million CNY | 61.36% |
| 2021 Q1 | 18.09 Million CNY | -57.67% |
| 2021 Q4 | 35.77 Million CNY | -5.19% |
| 2021 Q3 | 37.72 Million CNY | 29.23% |
| 2020 FY | 88.94 Million CNY | 31.22% |
| 2020 Q1 | 115.39 Thousand CNY | -99.51% |
| 2020 Q2 | 9.9 Million CNY | 8486.18% |
| 2020 Q3 | 36.18 Million CNY | 265.23% |
| 2020 Q4 | 42.73 Million CNY | 18.1% |
| 2019 FY | 67.78 Million CNY | 105.5% |
| 2019 Q4 | 23.34 Million CNY | 0.0% |
| 2018 FY | 32.98 Million CNY | 40.17% |
| 2017 FY | 23.53 Million CNY | 0.0% |